 | Up a level |
Number of items: 1.
Camidge, Ross, Cappuzzo, Federico, Go, Jowell, Isaacson, Jeffrey, Litten, Jason, Park, Keunchil, Spigel, David R., Spira, Alexander, Vergnenegre, Alain, Wolf, Juergen, Yang, James Chih-Hsin and Mok, Tony (2015). TIGER-1: A Phase 2/3 Study of First Line Rociletinib or Erlotinib in EGFR-Mutant NSCLC. J. Thorac. Oncol., 10 (9). S. S427 - 1. NEW YORK: ELSEVIER SCIENCE INC. ISSN 1556-1380